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Abstract 
Introduction: The mother-to-child transmission (MTCT) of HIV refers to the transmission 
of HIV from an HIV-infected woman to her child during pregnancy, labour, delivery 
or breastfeeding. This is the most common form of HIV transmission to infants and children. 
Without treatment, the likelihood of transmitting HIV from mother-to-child ranges between 
15-45%. The national prevention of mother-to-child transmission (PMTCT) programme was 
first introduced in South Africa in 2001. Effective PMTCT programmes require women and 
their infants to receive a cascade of interventions including HIV testing during pregnancy, 
use of antiretroviral treatment (ART) by pregnant women living with HIV, safe childbirth 
practices and appropriate infant feeding,  infant HIV testing and other post-natal healthcare 
services. The aim of this study was to describe Prevention of Mother-to-Child Transmission 
of HIV services among private general practitioners participating in a partnership programme 
with the Aurum Institute, assessing compliance to PMTCT Guidelines 2008 and 2010 as well 
as the MTCT rate at around six weeks. 
Methods: This was a retrospective review of records of women who enrolled into the 
PMTCT programme with the private general practioners affiliated to the Aurum Institute 
between January 2008 and April 2010. A total of 301 files of women enrolled on the PMTCT 
programme were reviewed. Data were collected from the women’s files and the Aurum 
database using a data abstraction form.  
Results: Even though HIV and TB guidelines were provided to all GPs, only less than 40% 
had copies of the guidelines in their general practice during the audit conducted in 2010.  The 
GPs adhered to the 2008 and 2010 PMTCT Guidelines and even exceeded the NDoH target 
when it came to CD4 count testing and provision of lifelong ART to those who were eligible.  
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In 2008, 91% of HIV positive pregnant women were tested for CD4 count, 99% were given 
lifelong ART and 74% of HIV exposed babies were tested at approximately six weeks by 
PCR. GPs did not adhere to guidelines in the provision of PMTCT prophylaxis where 21, 3% 
of women received prophylaxis and 77% of women received lifelong ART even though they 
were only eligible for prophylaxis. . GPs adhered to 2010 PMTCT guidelines regarding CD4 
testing and provision of lifelong ART. Baseline CD4 count was completed in 93% of women 
and 94% received lifelong ART. In 2010, PCR testing was conducted in 66% of HIV exposed 
babies, which was lower than the NDoH target of 80%. The overall MTCT rate in this study 
was 1.8%; a lower MTCT rate among women who became pregnant on ART than those 
initiating ART during pregnancy (0% versus 3.2%).  
Conclusions and Recommendations: The GPs affiliated to The Aurum Institute showed 
good adherence to the PMTCT guidelines at most steps of the PMTCT cascade, for example: 
CD4 count testing and provision of ART. The study concludes that with proper training, 
support and mentoring, GPs can render comprehensive PMTCT services. The study also 
concludes that later initiation of ART had increased risk of MTCT and that women who 
received ART compared to prophylaxis had a lower MTCT rate. Further research is 
recommended to evaluate HIV and TB services rendered by GPs not affiliated or in private 
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INTRODUCTION AND LITERATURE REVIEW 
1.1 Background 
Human Immune Deficiency Virus (HIV) is an important global health problem. World Health 
Organization (WHO) estimated that thirty five million people were living with HIV globally 
in 2013 (1). An estimated 0.8% of adults aged 15-49 years worldwide are living with HIV 
(1). Although the burden of the epidemic continues to vary considerably between countries 
and regions, Sub-Saharan Africa remains most severely affected, with nearly 1 in every 20 
adults living with HIV and accounting for 71% of the people living with HIV worldwide (1). 
The 2013 mid-year population estimates in South Africa showed that the overall HIV 
prevalence was approximately 10% (approximately 5.3 million people). For adults aged 15–
49 years, an estimated 15, 9% of the population were HIV positive (2). 
 
HIV is a main cause of child morbidity and mortality in South Africa, with HIV-related 
deaths accounting for more than one third of the total number of deaths in children under the 
age of five years (3). Vertical transmission (either in utero, during birth or postpartum during 
breastfeeding) is the main mode of HIV acquisition in these children (3). If a pregnant HIV 
positive woman does not receive antiretroviral drugs during pregnancy or labour, the risk of 
transmitting HIV to unborn baby is 15-30% and 15-20% during breastfeeding (3).  
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The prevention of mother-to-child transmission (PMTCT) programme was first introduced in 
South Africa in 2001. During that year, the HIV prevalence among the antenatal clinic 
attendees was 24.8% (4).  
Since the introduction and implementation of the PMTCT programme throughout the 
country, the HIV prevalence among antenatal attendees has remained unchanged for the past 
four years (5). The data reported above excluded data collected from private General 
Practitioners (GP). The 2010 National PMTCT policy recognises that in order to prevent HIV 
from among women and children, the four elements of PMTCT are integral. These include: 
1. Primary prevention of HIV, especially among women of childbearing age 
2. Preventing unintended pregnancies among women living with HIV 
3. Preventing HIV transmission from a woman living with HIV to her infant; and 
4. Providing appropriate treatment, care, and support to women living with HIV and 
their children and families (6). 
 
The South African PMTCT Guidelines (6 states that all pregnant women should be offered an 
HIV test at their first antenatal visit (6). Pregnant women who test HIV positive should be 
staged according to WHO staging and blood taken for CD4 count. If stage 3 and 4 or CD4 
count less than 350, should be provided with lifelong ART both for their own health and for 
prevention of MTCT to the baby. If stage 1 and 2 or CD4 count above 350, should be given 
PMTCT prophylaxis from as early as possible until after one week post-cessation of 
breastfeeding (6). In April 2013, South Africa introduced new regimens for HIV positive 
pregnant women. The PMTCT Guidelines requires that all HIV positive women should 
receive triple therapy of ARVs in a fixed dose (7). This was after the World Health 
Organization (WHO) released new guidelines which stated that all HIV positive pregnant 
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women should receive triple therapy (8).  The private sector (both for-profit and not-for 
profit) plays an important role in providing health care in South Africa.  In 2006, 58% of 
general practitioners (GPs) and 63% of specialists (e.g. gynaecologists, paediatricians etc.) 
were working in the private sector (9).  
Statistics from the Health Profession Council of South Africa (HPCSA) indicated that almost 
1 300 GPs were registered to practice in 2006 (9). The large percentage of medical 
practitioners working in the private sector warrants that delivery of any public health 
interventions are inclusive of this group.  According to the 2003 South African Demographic 
and Health Survey, 6% of women delivered their babies at private sector facilities, a number 
which may have increased over the years as access to medical insurance improves (10). 
These women may have received antenatal care including PMTCT from private practitioners. 
  
Since 2003, The Aurum Institute, a non-profit organisation has received funding from the 
United States’ President’s Emergency Fund for AIDS Relief (PEPFAR) to support the scale 
up of the HIV prevention, care and treatment programme in South Africa. In 2004, Aurum 
entered into a partnership with private GPs to provide HIV care and treatment services to 
HIV- infected patients. In the partnership, Aurum provided the GPs with initial and on-going 
training and mentoring on HIV management including PMTCT, ARV drug supplies, funding 
for laboratory services and patients’ consultation fees. The general practitioners on the other 
hand provided patient care and recorded all patient visits and consultations on Aurum 
designed patient management forms. The patient management forms were completed in 
duplicate; with the original copy remaining at the general practitioner and a copy being sent 
to Aurum Institute for data capturing and filing. 
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The services offered by the GPs included  HIV counselling and testing for children, adults 
and pregnant women, provision of antiretroviral therapy (ART) and ARV  prophylaxis for 
eligible women, prophylaxis for HIV exposed infants, HIV testing for HIV exposed infants at 
6 weeks and 18 months, counselling on feeding options and HIV treatment for children who 
test HIV positive.  
This research report describes a study that was conducted to assess compliance with National 
PMTCT Guidelines by general practitioners following the PMTCT cascade or processes.  
The study describes the overall mother-to-child transmission rate and practices at the general 
practitioners’ sites regarding provision of PMTCT.  
 
1.2  Statement of the problem 
The researcher hypothesised that the provision of PMTCT services and compliance to 
national guidelines differed between GP practices and that there were practice level factors 
which were associated with outcomes and compliance to guidelines. This was apparent due to 
the fact that some doctors would send prescriptions which did not follow the national 
guidelines, whereas other doctors would stick to the national guidelines, even though all 
doctors received the same training and received updates of guidelines on a regular basis. 
 
Identifying practice level factors that are associated with better patient care, and giving 
feedback on identified problem-areas (regarding compliance with guidelines) to the GPs, 
might assist in them scaling up their level of HIV/PMTCT care. When properly trained and 
supported, private GPs could play an important role in providing PMTCT services, thereby 
contributing towards reducing under five mortality and elimination of mother-to-child 
transmission.  








1.3 Justification for the research 
There is not enough information and evidence on the provision of PMTCT services by private 
GPs, their compliance with national guidelines, the outcomes of these services and the factors 
associated with healthcare services provided by private GPs in South Africa.  
Unlike public sector service providers who are evaluated regularly, private GPs often work in 
isolation and with minimal supervision. Their activities are rarely monitored and their patient 
outcomes not evaluated.  There are pregnant women who receive antenatal care, receive HIV 
counselling and testing, ART for PMTCT and infant polymerase chain reaction (PCR) testing 
from private practitioners. There is little evidence on how well GPs in private practice 
comply with PMTCT guidelines when they provide services to HIV positive mothers. 
Although the GPs involved in the partnership received training and support on HIV care and 
treatment from Aurum, this would not guarantee compliance with the National PMTCT 
Guidelines. This study maybe more significant in recent years with the introduction of GP 
contracting within the National Health Insurance (NHI) where GPs will be rendering their 













1.4 Literature review 
 
1.4.1 PMTCT missed opportunities 
There are gaps and missed opportunities in the provision of PMTCT services in both public 
and private sectors and these are related to patients, service providers and institutions.  . 
According to a national HIV/TB review conducted in 2014, uptake of PMTCT services was 
high with more than 98% of women getting HIV tested during pregnancy and 91.7% of HIV-
positive mothers receiving ARV treatment or prophylaxis (10). However, CD4 testing 
(78.3%) and early infant diagnosis (EID) uptake (35.1%) were lower and represented on-
going missed opportunities in the PMTCT programme (10). 
In the public sector, evaluation of the provision of PMTCT services across the world have 
shown improvements in access, coverage and outcomes, such as low rates of mother to child 
HIV transmission(11). 
  
A study evaluating infant early HIV diagnosis in primary health care settings in South Africa, 
showed that more than 90% of facilities reported offering any onsite PMTCT service, but 
only 69% of these facilities offered PMTCT services daily (12). This highlights that there are 
gaps in public health facilities where PMTCT services are not offered daily, therefore missing 
opportunities of identifying HIV infected mothers and children. 
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 The HIV epidemic in South Africa calls for efficient use of human resources for health to 
ensure increased coverage of treatment services. HIV treatment coverage in South Africa has 
faced numerous challenges with poor patient retention, suboptimal adherence and treatment 
failure due to poor access to services (13).  
  
 Broad Reach Healthcare (BRHC) developed a private-sector treatment model to provide an 
augmentative solution for accessing HIV care for patients in the public sector (13). They 
provided training to GPs and surgery staff on a range of topics related to HIV/AIDS 
management, including clinical management, the moral, ethical and legal issues of HIV 
disease management, and the administrative and logistical issues related to improving care in 
Mpumalanga and Kwazulu Natal (13). The evaluation of the programme showed that the 
private-sector treatment model combined with adherence support resulted in low defaulter 
and higher patient retention rates as compared to reports from public-sector models (13).  
These findings suggest that providing HIV treatment for patients in the private-sector is a 
suitable model to rapidly augment public-sector capacity (13).  
  
The Aid for AIDS (AfA) programme provides HIV/AIDS and TB services, including 
establishing a patient’s HIV status, providing clinical assessment, provision of care and 
treatment (including PMTCT), ongoing monitoring, and medicine supply from their preferred 
or network doctor (14). In 2006, a study reviewing the delivery of HIV and AIDS, sexually 
transmitted infections and tuberculosis care within the private sector, reported a relatively 
low mother-to-child transmission rate of 1.2% in women who received HAART from private 
sector doctors. (14). 
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Similar to Broadreach and AFA, the Aurum Institute model of offering HIV/AIDS 
management showed that a properly managed private general practitioner based model can 
achieve comparable results to public service programmes. This partnership with private 
general practitioners’ model of HIV/AIDS management can be used to expand access to ART 
in areas where the public sector is unable to meet demand (15). 
 
1.4.2 Role of private health sector in PMTCT programme 
The role of the private health sector in delivering HIV/AIDS services is not well studied and 
established in many countries. A study was conducted to assess the role of private health 
facilities and pharmacies in HIV/AIDS service delivery in Ethiopian order to quantify the 
role of the private health sector in HIV/AIDS and TB services. It concluded that the private 
sector had increased access to reproductive health services in the country and identified it as a 
solid foundation upon which further public-private collaboration could be achieved and that it 
is an untapped resource that could contribute to increasing both access and quality of 
HIV/AIDS services (16). 
 
In South Africa the provision of PMTCT services is happening in both the public and private 
sector. The provision of PMTCT services by GPs has not been previously described or 
widely studied (proved refs of studies that you have identified). A study KwaZulu-Natal 
study conducted in 1999 to measure the prevalence of HIV among pregnant women at a 
South African private medical centre showed that only 30% of women were tested for HIV 
infection, and among these, 14% were identified as HIV-infected. (17). These missed 
opportunities are not happening in the private sector alone.  
 
 Page 22 
 
A study conducted in Chris Hani Baragwanath Hospital found that of 1 510 children 
admitted, 29.5% were HIV infected (18). The study further found that problems with PMTCT 
implementation in infants under 6 months, included lack of maternal antenatal HIV testing, 
poor uptake of maternal/infant Nevirapine prophylaxis, limited use of co-trimoxazole (CTX) 
prophylaxis and delayed PCR testing (18).   
A study conducted in KwaZulu-Natal reported that private sector doctors providing care to 
HIV infected patients, thought that they required more training/knowledge in certain clinical 
areas such as overall care, ARV therapy, therapeutic monitoring, side effects management, 
HIV prevention, psychological counselling, nutritional and special support, particularly for 
younger doctors as they were more involved in the management of HIV/AIDS   (17). 
  
HIV services must be fully decentralised and integrated into the fabric of the health system 
with every health worker within a facility equipped with the knowledge and skills to provide 
HIV services. This training can begin from pre-services undergraduate education and will 
enhance effectiveness, improve quality, and minimise or eradicate stigma and discrimination 
in all supported sites (19). Aurum Institute followed this approach and supported affiliated 
GPs through training and in-service workshops, mentoring (through calls, email) and also 
reviewed scripts sent in by GPs.  
 
1.4.3 HIV/AIDS (PMTCT) management training 
The need for training of health care workers in the HIV care and treatment has not only been 
highlighted by the private practitioners but also in public institutions. A study from Botswana 
reported that health care workers felt discomfort in managing HIV patients because of lack of 
knowledge and training. This affected the country’s PMTCT program negatively because in 
 Page 23 
 
2003 only about 30% of pregnant women were tested for HIV, an area were HIV prevalence 
was around 40% (20).  While addressing the health care worker training needs it is also 
important to look at the site or provider level factors affecting the delivery of PMTCT 
services.  
 
Studies have been conducted at public institutions to look at the site level factors affecting 
PMTCT delivery but little is known about these factors in the private sector.  
Some of the issues to look at are whether the doctors’ knowledge about HIV/AIDS, their 
willingness to treat patients with HIV/AIDS, available infrastructure and resources, among 
others.  A study assessing public-private partnership in HIV treatment, showed that private 
sector GPs are able to effectively maintain patient treatment outcomes and potentially 
contribute to HIV treatment scale-up with the relevant support mechanisms in place. The 
model demonstrated how an assisted private sector based programme can be effectively and 
efficiently used to  target specific health concerns, key populations or serve as a stop-gap 
measure to meet urgent health needs (21). 
 
A study conducted in Kenya in 2005 found that participant-level factors (such as age, 
education etc.) were not significant determinants of PMTCT HIV test acceptance (22). The 
study recommended that PMTCT programmes should evaluate the role of site-level (provider 
and testing service) factors on PMTCT acceptance (22). The findings of the study suggested 
that the identification and improvement of site-level factors could improve PMTCT uptake. 
On the basis of published literature, training and availability of site staff (counsellors, nurses 
and physicians), participation of physicians and nurses in offering PMTCT HIV testing, 
instituting a better participant flow to minimize inconvenience, availability of test kits and 
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laboratory technicians at the site and the time required to return HIV test results are some of 
the possible factors that could play a role in determining test and PMTCT acceptance (22).  
 
Factors like these compromises patient care e.g. without HIV test kits no HIV test will be 
done to patients, without CD4 count results it was difficult to decide on ART regimen for the 
pregnant woman, until the new PMTCT Guidelines which states that all HIV positive 
pregnant women should be given triple therapy. 
 
Botswana experienced a low uptake of PMTCT services in public facilities in 1999-2003 
(20). A survey conducted in Botswana to determine the causes for low uptake of PMTCT 
services, reported that patient level factors like fear, stigma or resistance from partners were 
not frequent reasons for refusing an HIV test and PMTCT services (20). However, providers 
of HIV services reported discomfort in managing HIV positive patients due to their lack of 
knowledge and skills and were not confident enough to offer patients HIV testing (20). The 
PMTCT cascade starts with prevention of HIV, HIV test, without HIV test results it means no 
PMTCT intervention will be offered to those who need it. Thus, both site-level and patient-
level factors need to be addressed in order to increase the effectiveness of HIV/PMTCT 
services. 
 
South Africa has introduced National Health Insurance (NHI) and is currently in the pilot 
phase of implementation in eleven districts. The NHI is intended to bring about health care 
reform that will improve service provision. It will promote equity and efficiency so as to 
ensure that all South Africans have access to affordable, quality healthcare services 
regardless of socio-economic status (23). As part of health care system reform, primary 
health care services will be delivered through accredited and contracted private providers 
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practicing within a district (23). Research studies advocates that all GPs to be contracted in 
the NHI should be assessed or screened to identify their competency in the HIV diagnosing 
and managing patient living with HIV/AIDS as well as undergo HIV/AIDS prevention, 





In conclusion, the studies above showed that GPs are providing HIV and PMTCT services on 
different scales. They also emphasise the important role which can be played by GPs in 
providing HIV care including the provision of PMTCT services. It is also clear that there is a 
need to provide training and mentoring on HIV management to private GPs.  
We have seen from the studies above that GPs are willing to be integrated into the health 
system and offer comprehensive HIV services.  
 
1.5 Aims and objectives 
1.5.1. Study aim 
The aim of the study was to describe Prevention of Mother-to-Child Transmission (PMTCT) 
of HIV services among private general practitioners participating in the Aurum Programme 
during the period January 2008 and April 2010. The study also intended to explore the 
provision of PMTCT services by the general practitioners in respect to compliance to NDoH 
PMTCT guidelines, overall MTCT rate and site level factors e.g. training, staff categories etc. 
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1.5.2. Specific study objectives 
The specific study objectives were: 
1. To describe the practice levels factors (such as availability of HIV guidelines, 
availability of health care providers, type of trainings received) of GPs participating in 
the Aurum programme. 
2. To determine the compliance of GPs participating in the Aurum programme to 
National PMTCT Guidelines (relevant within the specified study period), with respect 
to the PMTCT cascade: CD4 count testing, prescription of treatment/prophylaxis, 
provision of ARV prophylaxis or ART regimens, and early infant HIV testing at 6 
weeks. 
3. To determine an overall mother to child transmission rate at around 6 weeks (4 – 12 




























This chapter describes the methodology used to conduct the research study on prevention of 
mother to child transmission of HIV services by private general practitioners affiliated to 
Aurum Institute HIV programme. The research study design, study population and sample, 
data collection method, data analysis and ethical considerations will be discussed.   
 
2.2.Setting  
The Aurum Institute developed a model for HIV care (including ART provision) using 
private practitioners with donor funding from the President's Emergency Plan for AIDS 
Relief (PEPFAR), which commenced in January 2005. The private practitioner model of 
ART delivery was a centrally-managed programme which included HIV specialist support, 
HIV training, data management, laboratory and pharmaceutical services. Treatment regimens 
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and initiation criteria for provision of ART were in accord with South African national 
guidelines. 
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Table 2.2.1 Description of 2008 and 2010 PMTCT Guidelines used during the study period 
2008 PMTCT Guidelines 2010 PMTCT Guidelines 
HIV positive pregnant women with CD4 
count of >200 were eligible to be initiated 
on AZT at 28 weeks gestation. 
HIV positive pregnant women with CD4 
count >350 or WHO clinical stage 1 or 2 
were eligible to receive AZT as early as 14 
weeks. 
HIV positive pregnant women with CD4 
count of ≤200 or WHO stage IV, they were 
eligible for lifelong ART. 
HIV positive pregnant women with CD4 
count ≤ 350 or WHO clinical stage 3 or 4 
were eligible to be initiated on lifelong ART  
 
In order to qualify to provide HIV management in partnership with Aurum, a doctor had to 
attend ART training course provided by Aurum, and it was also dependent on the availability 
of funds. The Aurum partnership with the GPs was audited for HIV patient retention in 2010. 
During the audit, data on the characteristics of general practices were collected on 
standardized audit forms. This data were used to describe the site level factors influencing 
compliance to the national PMTCT guidelines 2008 and 2010. The study included private 
general practices affiliated to Aurum Institute from nine Provinces in South Africa (table 
2.2.2). 
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Table 2.2.2 Distribution of General Practices 
Province Name Number of private GPs 
Eastern Cape 1 
Free State 5 
Gauteng 34 
KwaZulu-Natal Provinces 1 
Limpopo 7 
Mpumalanga 4 
North West 7 
Northern Cape 1 
Western Cape 1 
Total 61 
 
PMTCT services were introduced by the Aurum GPs in late 2008. However as there was no 
person who was coordinating the PMTCT activities at Aurum during this period, and thus 
there was poor coordination of PMTCT services provided by GPs participating in the Aurum 
programme. The PMTCT leader was only appointed in 2009, and new PMTCT enrolments 
stopped in May 2010 due to funding constraints. Those who were already enrolled in the 
programme continued receiving the PMTCT services through participating GP practices.  
 
2.3.Study Design  
A descriptive, cross-sectional study was used to review the compliance to national PMCT 
guidelines by private general practitioners affiliated to Aurum Institute.  
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2.4. Study population  
The study population comprised HIV-infected pregnant women who received PMTCT 
services between January 2009 and September 2010 at GP practices affiliated with the 
Aurum Institute in all nine provinces.  Records from all general practices affiliated with the 
Aurum Institute in all provinces regarding the PMTCT services to all HIV-infected women 
were reviewed and records of women were included in the analysis according to the study 
inclusion criteria.  
 
The inclusion criteria for the study included the following:   
All HIV-infected pregnant women who were enrolled on PMTCT programme between 
January 2009 and September 2010 at general practices affiliated to Aurum Institute and 
babies born by HIV positive pregnant women receiving the PMTCT services at these 
practices during the same period were included in the study.  
 
Exclusion criteria 
 Women who received PMTCT services from private general practitioners affiliated to 
Aurum Institute before January 2009, due to poor coordination of the programme 
during this time. 
 Women already enrolled in the programme and who fell pregnant and received 
PMTCT services from October 2010, were excluded because new enrolment had 
stopped due to lack of funding.  
 
 




Three hundred and one women who received PMTCT through Aurum-affiliated GP practices 
during the period under observation were included in the study.  
 
2.6.Data sources and data collection 
Data were collected from the Aurum Institute database, patient files, and the audit which was 
conducted in 2010 by the Aurum Institute.  
 Aurum database: Aurum developed a patient management system and data collection 
tools for all the affiliate GPs. An assessment form and core record form were completed 
at the patient’s first visit. A laboratory form to record results and visit forms were 
completed during follow up visits. After completion of the forms, the practice retained the 
original copies (in patient files) and sent a duplicate to Aurum offices for data capturing. 
 Patient Files: The information on patient files were used to verify information collected 
from database. Comparing the two sources (database and patient files), patient files were 
found to be more reliable, had more recent information and were more complete as 
compared to the database.  
 The audit:  This was meant to check the retention of patients at the GP practice. It was a 
once off exercise conducted in 2010. All the GPs were visited and all the patients’ files 
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2.7.Measuring tool or instrument 
Two data extraction sheets were developed and used to extract data. Patient level data were 
collected from patients’ individual files and Aurum HIV care and treatment database. 
Practice level data was collected from the audit records. The data collection instruments are 
attached as annexures. 
 
2.8.Variables  
Data was collected at the GP practice level as well as the individual patient level.   
i) Practice level data: data for practice level variables were collected from the 
completed audit forms. The following data elements were extracted: availability of 
PMTCT/ART guidelines, availability of health care staff (nurse, doctor), and 
whether staff received and HIV-related training from Aurum. 
ii) Patient level data: patient level data collected include demographics, clinical and 
immunological status, treatment regimens, and infant feeding method at around six 
weeks, and PMTCT outcome. 
 
2.9.Data analysis 
Individual-patient data collected from file review were cleaned and entered into MS Excel 
and MS Access and each patient was assigned a unique identifier. All analyses were 
conducted using Stata 11.0.  The general practices were described in terms of practice level 
variables such as type of staff training received, availability of ART guidelines, availability 
of doctor and/or nurse/s.   
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The women who received PMTCT services through the partnership in terms of age, 
employment status, gravidity and parity, the chi-square test and Wilcoxon rank-sum test were 
used to compare women who were on ART at enrolment to those who were not. A p-value of 
< 0.05 was considered statistically significant. The  numbers of women receiving services at 
each practice and at each step of the PMTCT cascade were determined and  used to calculate 
the:  
  Proportion of registered HIV positive women who receive CD4 count testing  
 Proportion of  HIV-infected pregnant women receiving ARV prophylaxis  
 Proportion of  HIV-infected pregnant women receiving HAART  
 Proportion of HIV-exposed babies tested by PCR at around 6 weeks.  
 
MTCT rate - the overall transmission rate were determined as the total number of HIV 
exposed infants with a positive HIV DNA PCR at six weeks / total number of HIV exposed 
infants tested at six weeks.  
 
2.10. Ethical considerations 
Permission to access PMTCT data was obtained and granted by the Research Director at The 
Aurum Institute in 2011, before data was collected.  Ethics approval by University of 
Witwatersrand Human Research Ethics Committee (Medical) was obtained and granted in 
2012 (certificate number M121033). To protect patients’ identity, no patients’ names were 
used during the study process. The files were retrieved using the unique study number 
allocated to each patient enrolled in the study.  
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As this was a retrospective study there was no risk to the study participants, so no consent 




This chapter discussed the methodology used to conduct this study on private practitioners’ 
compliance to South African PMTCT 2008 and 2010 Guidelines and site level factors 
influencing compliance or non-compliance. A quantitative approach was used and a 
descriptive, cross-sectional research design was adopted. This chapter also discussed the data 
collection methods which was review of records (patients’ individual files and site level 
factors from the Aurum audit conducted in 2010). These instruments collected data looking at 
the PMTCT cascades (CD4 count testing, Provision of either PMTCT prophylaxis or ART. 
Site level factors included training, availability of doctor and/or nurses, availability of 
guidelines etc. Before data was collected, permission to access and use data was obtained 
from Aurum Institute and ethical clearance certificate was received from University of 
Witwatersrand. Patients’ confidentiality was maintained throughout.  
  
 Page 36 
 





This chapter describes the results of the study. The results presented in this chapter include a 
description of the study population, and the participating general practices; the general 
practitioners’ compliance to National PMTCT Guidelines for 2008 and 2010, as well as the 
MTCT rate.  The geographical location of the General Practitioners site were not linked to 
individual level data during data collection, as  a result a description of site level factors 
associated with compliance and the MTCT rate are not presented. Data collection took place 
from 13 to 29 November 2012. Data was collected using the data abstraction form. MS 
Access 2007 and MS Excel 2007 were used for data capturing and management. Stata 13 was 
used for the data analysis.  
 
3.2  Description of General Practitioners’ Sites 
 
3.2.1 Geographical Information 
The Aurum Institute had enrolled sixty six general practitioners across the country to provide 
HIV/AIDS services. The audit was conducted by Aurum Institute to understand the status of 
health care provision at the GP sites in 2010. It was conducted in all sixty six GP sites in the 
nine provinces. Below is the GP sites distribution across South Africa: 
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Figure 3.2.1.1 GP sites geographical distribution 
 
Figure 3.2.1.1 shows that Gauteng province had more GP sites than any other Province, 
followed by North West. 
 
3.2.2 Description of the general practices according to audit findings 
3.2.2.1 Availability of clinical guidelines 
HIV (adult, paediatric and PMTCT) guidelines were provided to all GP sites by the Aurum 
Institute at the start of the programme and new guidelines were introduced. Audit findings 
showed that these guidelines were not found or their presence verified at the time of audit 
(table 3.2.2.1). The majority of GP sites (69.7%) had Wellness/Pre-ART guidelines and only 
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Table 3.2.2.1 Availability of Clinical Guidelines 
Guidelines Number Percentage (%) 
HIV counselling and testing 22 33.3 
PMTCT 18 27.3 
Paediatric 18 27.3 
ART 18 27.3 
Post exposure 8 12 
Tuberculosis 7 10.6 
Pre ART/Wellness 46 69.7 
 
3.2.2.2 Patient Statistics 
In total, 19 838 files were issued to GPs. This includes PMTCT, adult and paediatric files. At 
the time of audit, only 12 135 patient files were found to be active, the rest were transferred 
out, lost to follow up, deceased or deregistered from the programme.  
 
Table 3.2.2.2 Patients statistics 
Item Number 
Total number of empty files ever issued 19838 
Total  number of active files (at time of data collection) 12135 
Total  number of deregistered files 6465 
Total number of  patient deaths 1418 
Total number of patients transferred out 585 
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3.2.2.3 Treatment statistics 
Only 224 patients were found to be on PMTCT from all sixty six GP sites (table 3.2.2.3), as 
compared to 301 PMTCT patients found on the Aurum database or with patient files kept at 
Aurum offices. The audit found that 9065 patients were started on ART. 
  
Table 3.2.2.3 Treatment statistics 
Item Number 
Patients on ART 9065 
Patients on Cotrimaxazole 6497 
Patients on INH prophylaxis 951 
Patients on PMTCT 224 
Number of Paediatric Patients 293 
 
3.2.2.4 Equipment and Assets 
Almost all GP sites had a desktop/laptop, fax machine, printer, internet access and an email 
account. These were used to send pharmacy scripts to Aurum Institute clinicians for review 
and authorisation and also to send patients visit forms in time.  
 
Table 3.2.2.4 Availability of technological equipment  
Item Number Percentage (%) 
Desktop/Laptop 55 83.3 
Fax machine 56 84.8 
Printer 56 84.8 
Internet access 56 84.8 
Email account 53 80.3 
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3.2.3 Training 
The audit findings showed that the following training were attended by doctors, nurses and 
lay counsellors working at the GP sites: 
1. Doctors attended a three-day HIV/AIDS management training course and a two-day 
clinical training course (provided by the Aurum Institute) which included ART 
regimens, adherence, adverse events and their management, changing treatment 
regimens, ART for children and tuberculosis (TB) treatment. 
2. Nurses attended a two-day training course which included ART regimens, adherence, 
adverse events and their management, changing treatment regimens, ART for children 
and TB treatment. In addition nurses attended PMTCT, and there were also training 
specific for initiating and managing children on ART and Tuberculosis. 
3. Other trainings attended by either nurses or counsellors include: 
 Basic HIV counselling and testing 
 Adherence counselling for adults and paediatric 
 Running support groups, reducing stigma and enhancing disclosure 
 Basic Tuberculosis 
 PMTCT for lay counsellors 
 
3.2.4 Staffing 
The audit findings showed that all GP sites had a medical doctor and nurse (professional or 
enrolled nurse). Most of the GP sites also had lay counsellors (76%) and 82% had 
administrative clerks.   
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3.3. Demographic characteristics of women 
 
The study included 301 women who received PMTCT services at designated GP sites 
between January 2008 and April 2010. A total of 117 (39%) women fell pregnant and 
enrolled on PMTCT while already on ART, whereas 183 (61%) women were not on ART. 
Table 3.2 shows that majority of women enrolled in the PMTCT programme were black 
(97%) and 3% had missing data. The median age of the women in this sample was 33 years 
(IQR 29-37 years), with most of the participants aged 30 years and older. Employment data 
was available on 106 of the 301 women enrolled, and 89% of the women in this study were 
unemployed.  
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3.4. Maternal characteristics  
Of the 301 women who presented at the GPs sites for PMTCT, 103 (62.5%) presented after 
20 weeks gestation (table 3.3).   Only 16.9% of women presented before 12 weeks gestation. 
The median gestational age at first visit was 24 weeks (IQR: 16-28 weeks). Women who had 
CD4 count done were 91% (273/301). Of these 95% (260/273) had CD4 count values 
recorded in their files. The median CD4 count was 288.5 cells/mm3 (IQR: 184.5-448.5 
cells/mm3).  Viral load was done on 52.2% (144/301) of women, and of these, 81.3% 
(117/144) had record of results of viral load in their files. Of women with results of viral load 
recorded in their files, 45.3% (53/117) had a viral load of less than 400 copies (virally 
suppressed). The median viral load was 7692 copies (IQR 1914-24207).  
The majority of women (58.5%), were categorised under WHO stage 1, followed by stage 2 
at 15% and stage 3 were 9.3%. No woman was categorised under WHO stage 4. 
Approximately 17% of women were either not clinically staged or data was not captured at 
the site, and 17.2% (52/301) had no record of WHO staging. Most women (82.1%) were 
receiving lifelong ART, only 15.3% were on ART prophylaxis and 2.6% had missing data 
(table 3.4).  
When comparing those who were already on ART and those who were not, more women 
already on ART booked before 12 weeks gestation (17%). Most women who were not on 
ART enrolled for PMTCT services after 20 weeks gestation (74%). CD4 count at enrolment 
was likely to be done on women who received prophylaxis as compared to those already on 
ART, the same with viral load. 
 




Table 3.4 Maternal Characteristics 
Clinical information Total number (%) Already on ART 
New PMTCT 
Enrolment 
Gestational Age at 
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Median viral load  
















































3.5. Obstetrics Characteristics 
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Most women had a normal vaginal delivery (82%), and 18% of women had a caesarean 
section. Women who were not on ART at enrolment had more caesarean section (15%) as 
compared to 11% of those already on ART.  


























3.6. Infant Characteristics 
There were two hundred and twenty-two (73.7%) live births in this study (table 3.5). The 
mean infant weight at birth was 3kg (SD: 0.62g). Most infants had a birth weight of between 
2.6-3kg (41.8%), with only 5% of infants with a birth weight below 2kg (5.3%). Infants from 
women already on ART were more, likely to be tested for PCR (81%) as compared to 67% of 
new enrolments. All infants who tested PCR positive were born by women who were not on 
ART at enrolment (3.2%). The majority of women exclusively formula fed their infants 
(63.1%), with only 7.3% (22/301) of women exclusively breastfeeding their infants. There 
were a small number of women who practised mixed feeding (1.3%).  
 
The overall MTCT rate for HIV exposed babies whose mothers were enrolled between 
January 2008 and May 2010 was 1.8%. There were also a number of infants who were not 
tested or who did not have record of results (27.3%).  
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3.7. Compliance to 2008 and 2010 national PMTCT Guidelines 
In 2008 – 2009, all pregnant women were to be tested for CD4 count as it would determine 
whether a woman is eligible for lifelong ART or for prophylaxis. Therefore all HIV positive 
pregnant women should have had a CD4 count test. Two hundred and twenty one (91%) of 
women had a CD4 count done as baseline, which is more than the target of 80% which was 
set by NDoH in table 3.7.1. The median CD4 count was 280 cells/mm3 (IQR: 179-438 
cells/mm3).  
 
All women in this study sample were on either prophylaxis or lifelong ART, regardless of 
whether they had a CD4 count done. Many women (77%) were given lifelong ART including 
those who qualified to be on prophylaxis. Of those who were eligible for prophylaxis but had 
received ART, 44% fell pregnant while already on lifelong treatment (table 3.7.1).  All 
women who were eligible for ART received ART, except one patient who did not have a 
record of receiving any treatment. The overall performance of GP PCR testing was 74% for 
HIV-exposed babies, which was higher than the 40% target from NDoH at the time of data 
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Table 3.7.1 Compliance to PMTCT 2008 Guidelines (per PMTCT Cascade) by General 
Practitioners affiliated to The Aurum Institute: (N=243) 
Data Element 





GP actual performance 
CD Count 
testing 
CD4 count to be done in 
all HIV positive pregnant 
women same day or at an 
earliest convenience. 
80% CD4 count done: 
221(91%) 




HIV positive pregnant 
women with CD4 count 
of >200 were eligible to 
be initiated on AZT from 
28 weeks gestation. 
80% CD4 count >200 




30 (21, 3%) 
Received Lifelong ART: 
108 (77%) 




HIV positive pregnant 
women with CD4 count 
of ≤200 or WHO stage 
IV 
No target CD4 count <200 
Eligible for Lifelong 
ART: 66 
 
Received lifelong ART: 
65(99%) 
No record: 01 (1%) 
PCR Testing Early infant HIV testing 
using HIV PCR at 6 
weeks of age irrespective 
of feeding option 
40% PCR done: 179 (74%) 
PCR not done or no 
record: 64 (26%) 
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Table 3.7.2 shows that CD4 count testing was done at 93% (54/58) of women and 7% (4/58) 
was either not done or no record of CD4 count done.  
The median CD4 count was 317 cells/mm3 (IQR: 217-461 cells/mm3). The 2010 PMTCT 
Guidelines required that all HIV positive women should be tested for CD4 count to assess 
eligibility for either lifelong ART or prophylaxis. Of those tested, 47% (22/54) were eligible 
for prophylaxis, but only 50% received prophylaxis (table 3.7.2). PCR testing in 2010 was 
lower 66% (38/58) as compared to 2008 PCR testing 74% (179/243).  
 
Table 3.7.2 Compliance to PMTCT 2010 Guidelines (per PMTCT Cascade) by General 
Practitioners affiliated to The Aurum Institute (N=58) 
Data Element 





GP actual performance 
CD Count 
testing 
CD4 count to be done in 
all HIV positive pregnant 
women same day or at an 
earliest convenience. 
None CD4 count done: 54 
(93%) 




CD4 > 350 and WHO 
stage 1 or 2 
80% CD4 count >350 




Received Lifelong ART: 
09 (41%) 




CD4 < 350 or 
WHO clinical stage 3 or 
4) 
30% CD4 count <350 
Eligible for Lifelong 
ART: 31 (53.4%) 
Received lifelong ART: 
29(94%) 
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No record: 02 (6%) 
PCR Testing HIV-exposed infants 
should be tested for HIV 
at 6 weeks of age, or 
before 6 weeks of age if 
they 
are sick 
80% PCR done: 38 (66%) 
PCR not done or no 
record: 20 (34%) 
 
 
3.8. Mother to Child Transmission rate at around six weeks 
The MTCT rate for women enrolled using 2008 National PMTCT guidelines was lower (1%) 
as compared to women enrolled during the period when 2010 PMTCT National PMTCT 
guidelines were in use (table 3.8). When comparing with NDoH target, GPs met the <5% 
target. In 2010, there was no MTCT target because of data collection issues. The table 3.4 
below shows the overall MTCT rate of 1.8%, which is less than below 2% target of reducing 
MTCT rate by 2015. Women who were already ART had no mother-to-child transmission, 
while women enrolled not on ART had 3.2% MTCT rate.  
 
Table 3.8 Mother-to-child transmission rate 
Description NDoH target GP Actual performance 
MTCT rate 2008/9 PMTCT Guidelines <5% 1% 
MTCT rate 2010 PMTCT Guidelines No target 5% 










DISCUSSION AND RECOMMENDATIONS 
 
4.1. Introduction 
This chapter discusses the findings of this study which aimed to describe the provision of 
PMTCT services among general practitioners affiliated with the Aurum Institute and their 
implications for PMTCT provision by GPs and in the public sector. The chapter also further 
discusses the strengths and limitations of the study and makes recommendations for further 
research in this area. The study found that GPs adhered to national PMTCT guidelines on 
CD4 count testing, provision of ART and PCR testing. Most women who were eligible for 
prophylaxis received ART. The overall MTCT rate was 1.8%. The study found that the 
MTCT rate was lower among women who became pregnant on ART than those initiating 
ART during pregnancy (0% versus 3.2%).  
 
4.2. Discussion 
4.2.1. Compliance to National PMTCT Guidelines according to PMTCT cascades 
Missed opportunities along the PMTCT cascade can increase the chances of infecting the 
unborn infant. In this study, women who were enrolled on the programme, were either tested 
for HIV elsewhere or at the GP site. There was no record available of where they were tested 
in the database that used for analysis in this study.  
 




4.2.1.1. CD4 count testing 
The 2008 National PMTCT Guidelines outlined specific interventions that were to be carried 
out for an HIV positive pregnant woman. These included issuing ART according to PMTCT 
clinical guidelines to prevent vertical transmission of HIV to the unborn baby. (27). 
Similarly, in the 2010 PMTCT guidelines, this was mentioned as one of the main aims of the 
National PMTCT programme (6). According to the  PMTCT clinical guidelines,  all HIV 
positive pregnant women should be clinically staged according to WHO staging and have 
their CD4 cell count taken on the same day as their HIV test, and preferably at the first ANC 
visit (or the earliest opportunity) (27,6). 
 
In comparison with the NDoH 2008/9 target,   80% of HIV positive pregnant women were to 
be tested for CD4 count, GPs enrolled in this study tested 91% of women and had exceeded 
the national target. Most women were tested for CD4 count at enrolment (91%) to assess 
eligibility for lifelong ART or prophylaxis. However, there were cases of women who were 
tested but their results were not recorded or where women did not have a CD4 count taken at 
all (<10%). This finding on CD4 count testing was similar to what was observed in Kwazulu-
Natal (17), which found that 2.9% HIV-positive women did not have a CD4 count done and 
an additional 31.3% did not receive their CD4 results (17). Similar to the findings in this 
study, the majority of the HIV-positive women in the Kwazulu-Natal study were initiated on 
either PMTCT Prophylaxis or lifelong ART at their first antenatal visit independent of their 
CD4 result. (24). A local study conducted in the Eastern Cape, also reported similar findings. 
(25).  




4.2.1.2. PMTCT Prophylaxis or Lifelong ART 
The provision of either lifelong ART or Prophylaxis was dependent on the results of the CD4 
count and clinical staging of women at first consultation. If these were not done, it meant the 
pregnant woman would not receive appropriate treatment. In the current National PMTCT 
guidelines, CD4 count is no longer an eligibility criteria for either lifelong ART or 
prophylaxis as compared to 2008 and 2010 National PMTCT guidelines (26).   
 
Some women in this study did not receive treatment as per the 2008 and 2010 National 
PMTCT Guidelines. Aurum GPs preferred to prescribe lifelong ART even when some 
women were eligible for prophylaxis and no justification for issuing lifelong ART was found 
in the patients’ files, except for 44% of women from 2008 who fell pregnant while they were 
already on ART. Although this was non-compliance with guidelines, it was in the best 
interest of the patient as later guidelines showed that lifelong ART regardless of CD4 count 
was better for the mother (8).  
 
The findings in this study concur with previous local studies (17). A Kwazulu-Natal study 
revealed that among the women who had a CD4 result, 48% were eligible for HAART 
according to the 2008 PMTCT guidelines, but 96.8% of the HIV positive women initiated 
dual ART prophylaxis for PMTCT independent of their CD4 result; and 9.2% of all HIV 
positive pregnant women initiated HAART (17). Among the women eligible for HAART 
(CD4<200 cells/mm
3
), 29.1% initiated HAART during their pregnancy and 18 (2.9%) of HIV 
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positive pregnant women did not receive any antiretroviral drugs for PMTCT or treatment 
(17). 
 
GPs participating in this study did not adhere to PMTCT treatment guidelines when 
prescribing prophylaxis as more women received lifelong ART even though they were 
ineligible. However, GPs adhered to national guidelines when prescribing lifelong ART to 
those who were eligible. The pharmacy prescriptions that were written by GPs were reviewed 
by clinicians at Aurum Institute, who in most cases changed the scripts to align them with 
guidelines.  
 
4.2.1.3. PCR testing at around 6 weeks 
There were approximately 34% of infants in this study who did not have a record of PCR 
testing at around six weeks of age in their mothers’ files. This does not necessarily mean that 
these infants did not undergo PCR testing, but they may have been tested at public clinics at 
their six weeks immunization visit. Some mothers brought the results of tests conducted at 
public health care facilities to their GP visits to avoid further testing but others were unable to 
produce results.  
 
Both the 2008 and 2010 National PMTCT guidelines mentioned one of its specific 
interventions as offering HIV testing using HIV PCR to HIV-exposed babies at six weeks 
immunization visit irrespective of whether the baby is breastfed or formula fed. (27,6). PCR 
testing conducted by Aurum-affiliated GPs in this study (at 72%) was higher than PCR 
testing coverage rates reported in similar studies in South Africa (17, 26).  
 
 Page 54 
 
 When comparing the results of this study with the NDoH performance of 2008-2010, the 
GPs in this study complied with the PMTCT Guidelines and performed above the national 
target of 40% and 80%. When using the 2008 PMTCT guidelines, GPs conducted PCR tests 
for 74% of infants, which was still above national target of 40%.  
When comparing to 2010 National PMTCT guidelines, GPs tested 66% of infants, which was 
below the national target of 80%, but above the NDoH actual performance of 54.6% (6).   
 
4.2.2. Mother-to-child transmission rate 
1.5.1.1 An overall mother to child transmission rate at around 6 weeks (4 – 12 weeks). 
The overall mother-to-child transmission from the Aurum-affiliated GP programme was 
1.8% in 2008 – 2010. For women who were enrolled using the 2008 PMTCT guidelines, the 
MTCT rate was 1% which was below the 5% NDoH target (27). This finding is consistent 
with previous studies which showed a relatively low mother-to-child transmission rate of 
1.2% in women who received HAART by doctors in the private sector (14). These results 
highlight the opportunities reflected by National Strategic Plan (NSP 2012-2016) for private 
sector doctors to respond to South Africa’s leading epidemics like HIV/AIDS (14).  
 
For those enrolled using the 2010 PMTCT guidelines, the MTCT rate was 5%, which may be 
explained by the small number of women who were enrolled using 2010 PMTCT guidelines 
(43 women). In this study, the four women who delivered HIV positive infants, all received 
ART while already pregnant. Previous studies showed that women who received ART while 
already pregnant have a greater chance of transmitting HIV to their infants (24). There was 
no target from NDoH in 2010 but MTCT rate higher than the UNAIDS global elimination of 
mother-to-child transmission rate of <2% by 2015. There are no comparable studies found 
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which evaluated MTCT rate at the GP sites in South Africa. Evaluations that have been 
conducted were on the contributions of GPs in the provision of HIV services and thereby 
contributing towards reduction of HIV and TB.  
The evaluation of the effectiveness of the national PMTCT programme conducted by MRC in 
2010, reported a MTCT rate of 3.5%, which was lower than the 2010 MTCT rate in this study 
(12). The overall MTCT rate of 1.8% showed that PMTCT programme offered by GPs was 
more effective as compared to the public sector programme, though GP had smaller patient 
caseload as compared to public sector. Despite unavailability of PMTCT/ART guidelines at 
GP sites at the time of audit in 2010, this did not affect the performance of GPs negatively, as 
the MTCT rate is still lower than the NDoH 2013/14 MTCT rate of 2% against the 2008/10 
GP MTCT rate of 1.8%.  
 
1.5.1.2 Mother-to-child transmission rate: Women enrolled on PMTCT while on ART 
versus women enrolled on PMTCT while not on ART 
Infants born to women who were enrolled on PMTCT while already on ART all tested 
negative at around six (6) weeks, meaning the MTCT rate for this group of women was 0%. 
All infants who tested PCR positive at around six (6) weeks were from women who were 
enrolled on PMTCT while not on ART. The MTCT rate of women who received ART while 
already pregnant was 3.2% as compared to 0% MTCT rate from women who were already on 
ART. The findings were similar to those from the study conducted in Johannesburg clinics 
between 2004 and 2008, which found that MTCT rates were lower in women who became 
pregnant on HAART than those initiating HAART during pregnancy (0.7% versus 5.7%), 
thus concluding that late initiation of HAART is associated with increased risk of MTCT 
(28).  







4.2.3 Site Level Factors  
The site level factors which were considered in this study included the availability of national 
PMTCT guidelines, the availability of health professions and the HIV/AIDS/TB training 
received by GPs and their staff.  The Aurum Institute (15), took the following factors into 
consideration when recruiting and enrolling GPs to participate into the programme and the 
site level factors observed in this study will be discussed using their criteria for enrolment 
onto the programme (15). 
 
4.2.3.1 Site Eligibility 
Site eligibility was important for this study in order to assess if GPs complied with what was 
expected from them. One of the criteria for enrolment of GP sites into the Aurum programme 
was that the GP and the nurse must attend the Aurum ART initiation training before they 
could be allowed to run the Aurum Institute HIV programme. Thereafter, Aurum Institute 
delegates assess the sites and provide the GP with patient files, guideline documents and data 
collection tools (15). Thus, all GPs sites were expected to have PMTCT/ART clinical 
guidelines for reference when consulting patients.  
 
4.2.3.2 Training 
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Training for the GPs and their staff was to assess their knowledge and skills to provide HIV 
services. The Aurum Institute offered various HIV/AIDS management training courses to all 
its affiliated GPs. These training courses includes:  
 Three day HIV/AIDS management training course before initiation of the site 
 Two day HIV/AIDS clinical training course which covered topics like ART treatment, 
ART adherence, adverse events, management of adverse events, tuberculosis 
management, ART for adults, adolescent and children. This course was intended for 
both doctors and Professional nurses. 
 PMTCT training course (15) 
Apart from the clinical courses offered to doctors and nurses, Aurum Institute offered the 
social courses which GPs were required to at least send a nurse or counsellor where there is 
any. These courses includes ART adherence counselling, running support groups, reducing 
stigma and enhancing disclosure, and ART adherence counselling for children (15). 
In addition to entry training, in service training were also provided to all doctors, nurses and 
other staff to keep them updated with new development regarding Guidelines and 
management of HIV positive patients. All general practitioners sites were given HIV/TB 
Guidelines for reference, and new Guidelines were also distributed as they were introduced 
(15).  All GP sites in this study, and their staff, had received HIV/PMTCT/TB training from 
Aurum Institute. This was in contrast to findings reported in prior studies, where GPs 
reported not feeling confident enough to diagnose, treat and manage HIV positive people 
because of lack of training (17). 
  
4.2.3.3 Ensuring quality 
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The Aurum Institute made sure that the programme run smoothly and that quality work was 
done, for example: all prescriptions from the GPs were first assessed by Aurum Institute 
clinicians to ensure they adhered to national HIV/AIDS/PMTCT clinical guidelines before 
they could be sent to pharmacy for dispensing of medication. The clinicians form Aurum 
Institute were also available to GPs to answer any clinical questions through email, 
telephones and site visits (15).  
Aurum Institute had site coordinators allocated to all GP sites to conduct monitoring visits 
every three months. During these monitoring visits, site coordinators would check patient 
files for completion, adherence to national HIV/AIDS/PMTCT clinical guidelines, and 
submission of clinical forms to Aurum Institute for capturing and answer any questions as 
much as they could (15). Patient files were selected randomly by site coordinators for 
assessment of above activities. Reports were produced and recommendations made (15).  
When comparing the study findings and measures which were put in place by the Aurum 
Institute in ensuring that GPs an effective HIV programme, it is probable that these measures 
contributed positively to the outcomes of this study.  
 
4.3. Strengths of the Study 
This study includes data of HIV positive pregnant women receiving PMTCT services at GP 
sites across all nine South African provinces affiliated to Aurum Institute. It is one of the few 
studies examining the public-private partnership between government and private GPs 
offering PMTCT services. 
 
4.4. Study Limitations  
The following study limitations have been identified: 
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 The study was only confined to private GPs affiliated to The Aurum Institute and users of 
their services. This does not mean that GPs not affiliated with Aurum Institute were not 
providing HIV and PMTCT services. This was for convenience of the researcher as an 
employee of Aurum Institute at the time that the study was conducted. Aurum Institute 
had access to data as a funder of this programme.  
 
 Because GPs from this study received considerable support in the provision of the 
services which includes training and mentoring of staff both onsite and offsite, provision 
of stationery and patients files, finance, provision of clinical guidelines, data capturing 
and quality assurance), the findings of the study does not represent all GPs providing 
PMTCT services and the women receiving PMTCT services through GPs in South 
Africa. Thus there are limitations to the generalizability of the study findings. 
 
 The PMTCT cascade starts with HIV testing and diagnosis and this component was not 
included in the study. Therefore, the association between the time of testing and outcome 
of PMTCT programme cannot be accounted for in the study.  
 
 As this was a retrospective record review, some relevant and very important information 
was missing due to incomplete data completion in the patient files. In some instances, the 
researcher used patient progress notes to obtain relevant missing data.  
 
 Data on labour and delivery were not included in the study as this service was not 
provided by the GPs and their staff. Though Nevirapine to swallow during labour was 
issued by GPs, there was no data which indicated that women swallowed Nevirapine and 
other labour and delivery drugs; and thus these practices cannot be accounted for in the 
study.  
 Page 60 
 
 
 The GPs audit was conducted at a single point in time in 2011 and the main reason for the 
audit (from Aurum Institute) was to quantify loss to follow up and to establish reasons 
behind these loss to follow ups. It was not meant to establish the site level factors 
contributing to either adherence or non-adherence to PMTCT guidelines.  
 
 The study sample was too small to find a significant association between PCR positivity 
rate and patient individual factors or site level factors. There was no dedicated employee 
from Aurum Institute who was coordinating PMTCT offered by GPs before 2008 and 
enrolment of women on PMTCT and HIV programme in general was stopped on the 30th 
April 2010 due to funding constraints. The outcome of the study might have been 
different if there were an increased number of participants.  
 
 The individual and site level data were not linked on data collection, which made it 
impossible to determine any association between individual and site level factors in the 
study. 
 
Despite these limitations, the data available provides useful information about the provision 




4.5.1 Recommendations for policy and practice 
According to data collected by the World Health Organization (WHO) in 2006, 
approximately twenty one percent of patients receiving antiretroviral therapy (ART) in six 
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African nations (Botswana, Kenya, Namibia, Nigeria, South Africa, and Uganda) were 
receiving treatment in the private sector (28). Despite these potential benefits, including 
private sector involvement in the national strategy for meeting HIV needs has often been 
overlooked in some regions due to quality concerns about provider training, prescribing 
standards, regular testing and monitoring of HIV patients, adequate counselling on 
prevention, and appropriate management of opportunistic infections, among other things (28). 
The findings for this study highlight the importance of public-private partnerships with GPs 
and also encourages such initiatives to reduce the workload at the PHC level. The following 
are recommended: 
 GPs should on a regular basis receive training and updates on HIV and TB care and 
management. 
 There should be mentoring and supervision of GPs by DoH to ensure that better quality of 
services are rendered. 
 HIV and TB clinical guidelines should be distributed to all GP sites and they should be 
mandated to follow NDoH guidelines, 
 GPs should provide monthly and quarterly reports to the nearest clinic/hospital for the 
services they are rendering for reporting purposes.  
 GPs should utilize the same data collection forms from DoH for HIV and TB services. 
 
4.5.2 Recommendations for further research 
There are limited studies conducted to evaluate services rendered by GPs globally and in in 
South Africa. Therefore, the study recommends that further research to evaluate HIV and TB 
services rendered by GPs not affiliated or in private public partnership with any institution be 
 Page 62 
 
conducted.  Further research is recommended to include the views of women or recipients of 
services to determine their experience of receiving HIV care through private GPs. 
 
4.6. Conclusions 
The GPs adhered to most of PMTCT cascades and exceeded the NDoH target for CD4 count 
testing in 2008 and 2010, ART provision in both 2008 and 2010 and PCR testing in 2010 
National PMTCT guidelines. GPs did not adhere to provision of PMTCT prophylaxis, as 
most women who were eligible for prophylaxis received lifelong ART. Though all GPs were 
provided TB and HIV guidelines, during the audit most of the GPs did not have guidelines at 
their sites at the time of audit. The study concludes that with proper training, support and 
mentoring, private GPs can render comprehensive PMTCT and HIV services. The study also 
highlighted the need for ongoing training and mentoring of GPs contracted to the NHI pilot 
districts and seconded to the primary health care facilities (PHC).  Proper use of National 
PMTCT Guidelines coupled by public private partnership plus the above mentioned 
recommendations can assist in further the reduction in the MTCT rate in South Africa and 
other countries facing similar challenges.  
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Title: Prevention of mother to child transmission of HIV practices by private 
general practitioners affiliated to the Aurum Institute.  
Data abstraction form: individual 
level data 
 
 1.  Client code       
 Site Number: 
 
 
2.  Date data abstracted from client’s record      
 
       
Day Month Year 
 
 3.  Time data abstraction commenced (24 hour clock) 
hrs. 
 4.  Date enrolled in the HIV care at GP practice          




 1.  Was the client  registered for  PMTCT services through an Aurum affiliated doctor  
00=No; 01=Yes 
  
 2.  Date client registered for PMTCT    
  
       
Day Month Year 
 
 3.  Is the client eligible for inclusion into the study? (client is eligible if answer for Q1= Yes 
and client is registered  between January 2009 and September 2010)  
00=No; 01=Yes  
 




1.  Client’s date of birth 
  01/JAN/97 = N/A       01/JAN/98 = missing CRF data 
  
       
Day Month Year 
 
 2.  Age 
 
 3.  Client’s ethnicity 
01=Black/African                                   02=Coloured/Mixed Race 
03=Indian/Asian                                    04=White/European 
05=Other, record  
98=Missing CRF data                            
 
If other specify: 
 4.  Employment status at enrolment 
01=employed 
02=unemployed 
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Clinical information 
 1.  Gestation age at first visit (weeks) 
 
  
 2.  Gestation age at initiation of PMTCT Prophylaxis or PMTCT HAART  (weeks) 
 
  
 3.  Was the client already on HAART at PMTCT enrolment? 
00=No, 01= Yes  
 
 4.  Type of treatment/drug regimen 
 
01= PMTCT prophylaxis (AZT from 14 weeks or later)    02=PMTCT HAART (TDF+3TC/FTC+NVP or 
EFV)  03=AZT+3TC+NVP   04= Other  05=No treatment  98= missing data in the records 
 
Explain…………… 
 5.  Date treatment prescribed        
Day Month Year 
 
 6.  Date treatment issued        
Day Month Year 
 
 7.  WHO clinical stage 
 
01 = Stage 1 or 2    02= Stage 3   03=Stage 4    98= missing data in the records 99= not done  
 8.  Was baseline viral load done? 
00=No; 01=Yes 
 









       
Day Month Year 
 
 9.   
Was the baseline CD4 count done? 
00=No; 01=Yes 
 
Baseline CD4 count (cells/mm3) 
 
 






       
Day Month Year 
 
 
 10.  Type of delivery 
 
01= NVD   02=C/Section    98= missing data in the records  
 11.  Birth outcome  
 
01= Live birth    02=Still birth     03= Abortion/miscarriage  04=Neonatal death  05=Loss to follow up 
97= N/A  (did  not give birth)    98= missing data in the records 
 
 12.  Current feeding method reported at around 6 weeks 
 
01= Exclusive breastfeeding   02= Exclusive formula feeding  03= Mixed feeding 98= missing 
data in the records 
 





 13.  Birth weight  
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 14.  Was the PCR done? 
00=No; 01=Yes  98= missing data in the records 
 
 15.  PCR result 
 
01= HIV negative   02=HIV positive  98= missing data in the records  
 16.  Date PCR done        
Day Month Year 
 
 
Completion of data abstraction 
 1.  Time data abstraction completed 
hrs 
 2.  Initials of person abstracting data  
 3.  Signature of person  abstracting data  
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Title: Prevention of mother to child 
transmission of HIV practices by private 
general practitioners affiliated to the Aurum 
Institute. 
Data abstraction form: Practice level data 
Date of audit:  
       
Day Month Year 
 
Time data abstraction commenced (24hour clock):  
1. Geographical information 
Province: 
 




 At the time of audit did the site have?   00 = No, 01 = Yes 
2.1 HIV counselling and testing guidelines  
2.2 PMTCT guidelines  
2.3 Paediatric guidelines  
2.4 ART guidelines   
2.5 Post exposure prophylaxis guidelines  
2.6 Tuberculosis guidelines  
2.7 Pre-Art/Wellness guidelines  
 
3. Statistics at the time of audit 
3.1 Total number of empty files ever issued  
3.2 Total number of current active files  
3.3 Total number of  deregistered files  
3.4 Total number of death  
3.5 Total number of transfer out  
3.6 Total number of lost to follow up  
 
4. Patients on treatment/prophylaxis in the practice at the time of audit 
Total Number of: 
4.1 patients on ART  
4.2 patients on  Cotrimaxazole Prophylaxis  
4.3 patients on  INH Prophylaxis  
4.4 patients on PMTCT Programme  
4.5 paediatric patients on ART  
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5. Staffing and Training at the time of audit 
 


















6. Equipment’s and assets 
 At the time of audit, did the practice have: 00 = No, 01 = Yes 
6.1 Desktop/Laptop computer  
6.2 Fax machine  
6.3 Printer  
6.4 Internet access  
6.5 Email address  
 
 Time data abstraction completed (24hour clock)  
 Initials of person abstracting data  
 Signature of person abstracting data  
 
  




   
